Selective Renal Denervation Guided by Renal Nerve Stimulation in Canine.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 23 7 2019
medline: 23 11 2019
entrez: 23 7 2019
Statut: ppublish

Résumé

Renal nerve stimulation (RNS) can result in substantial blood pressure (BP) elevation, and the change was significantly blunted when repeated stimulation after ablation. However, whether RNS could provide a meaningful renal nerve mapping for identification of optimal ablation targets in renal denervation (RDN) is not fully clear. Here, we compared the antihypertensive effects of selective RDN guided by two different BP responses to RNS and explored the nerve innervations at these sites in Kunming dogs. Our data indicated that ablation at strong-response sites showed a more systolic BP-lowering effect than at weak-response sites (P=0.002), as well as lower levels of tyrosine hydroxylase and norepinephrine in kidney and a greater reduction in plasma norepinephrine (P=0.004 for tyrosine hydroxylase, P=0.002 for both renal and plasma norepinephrine). Strong-response sites showed a greater total area and mean number of renal nerves than weak-response sites (P=0.012 for total area and P<0.001 for mean number). Systolic BP-elevation response to RNS before RDN and blunted systolic BP-elevation to RNS after RDN were correlated with systolic BP changes at 4 weeks follow-up (R=0.649; P=0.012 and R=0.643; P=0.013). Changes of plasma norepinephrine and renal norepinephrine levels at 4 weeks were also correlated with systolic BP changes at 4 weeks (R=0.837, P<0.001 and R=0.927, P<0.001). These data suggest that selective RDN at sites with strong BP-elevation response to RNS could lead to a more efficient RDN. RNS is an effective method to identify the nerve-enriched area during RDN procedure and improve the efficacy of RDN.

Identifiants

pubmed: 31327262
doi: 10.1161/HYPERTENSIONAHA.119.12680
doi:

Substances chimiques

Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

536-545

Commentaires et corrections

Type : CommentIn

Auteurs

Hang Liu (H)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Weijie Chen (W)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Yinchuan Lai (Y)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Huaan Du (H)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Zihao Wang (Z)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Yanping Xu (Y)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Zhiyu Ling (Z)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Jinqi Fan (J)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Peilin Xiao (P)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Bo Zhang (B)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Jie Wang (J)

Department of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY (J.W.).

Laxman Gyawali (L)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Bernhard Zrenner (B)

Medizinische Klinik I, Krankenhaus Landshut/Achdorf, Germany (B.Z.).

Kamsang Woo (K)

Institute of Future Cities, the Chinese University of Hong Kong, China (K.W.).

Yuehui Yin (Y)

From the Department of Cardiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing Cardiac Arrhythmias Therapeutic Service Center, China (H.L., Y.L., W.C., H.D., Z.W., Y.X., Z.L., J.F., P.X., B.Z., L.G., Y.Y.).

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH